Delivery Order SPE2DR25D1053-SPE2DR26FT597
Award Date 11/4/25
Potential Completion Date 11/5/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $13,844.36 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Rytary ER (carbidopa-levodopa extended-release) 36.25 mg-145 mg capsules in a quantity of 100 units. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive set-aside award. The product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Rytary ER (carbidopa-levodopa extended-release) 36.25 mg-145 mg capsules in a quantity of 100 units, with a ceiling value of $3,902.75. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is expected to be completed by November 4, 2025, and will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $44,283.84 to AmerisourceBergen Drug Corp for the supply of RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in a quantity of 100 units. The contract is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and was awarded on June 6, 2025 without any set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $17,984.04 firm fixed-price delivery order for RYTARY ER (carbidopa-levodopa extended-release) 61.25 mg-245 mg capsules, 100-count bottles, with an ultimate completion date of June 9, 2025. This is a competitively awarded, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Rytary ER (carbidopa/levodopa extended-release) 36.25 mg-145 mg capsules in a quantity of 100 units, valued at $5,499.64. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order valued at $2,102.87 to AmerisourceBergen Drug Corp for RYTARY ER 48.75 mg–195 mg capsules (100 count) on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $11,742.38 to AmerisourceBergen Drug Corp for Rytary ER 48.75 mg-195 mg capsules (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. Rytary is a carbidopa-levodopa extended-release medication used to treat Parkinson's disease...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,680.89 on October 17, 2025, for the supply of Rytary ER 36.25 mg-145 mg capsules (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and performance scheduled to be completed by October 20, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,770.64 to AmerisourceBergen Drug Corp for RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in a quantity of 100 units. The order, executed on September 24, 2025, with an ultimate completion date of September 25, 2025, utilizes firm fixed pricing under a competitive, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order through its...
- This delivery order, awarded August 28, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in quantities of 100 units. The contract carries a ceiling value of $10,351.48 and represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The award was competitively procured without set-aside designation and is being performed at...